Oakland, CA, United States of America

Eric L Schneider

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • San Francisco, CA (US) (2016)
  • Oakland, CA (US) (2018 - 2019)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric L Schneider

Introduction

Eric L Schneider is a notable inventor based in Oakland, CA, who has made significant contributions to the field of biotechnology. With a total of six patents to his name, Schneider's work focuses on the development of advanced conjugation linkers and innovative conjugates for somatostatin analogues. His inventions have the potential to enhance the efficacy of therapeutic agents in medical applications.

Latest Patents

Among his latest patents, Schneider has developed β-eliminative linkers that are suitable for the conjugation of small molecules, peptides, and proteins. These linkers are crucial for creating effective drug delivery systems. Additionally, he has worked on conjugates of carriers and hydrogels that control the biological half-life of somatostatin and its analogs, which can significantly improve treatment outcomes for patients.

Career Highlights

Throughout his career, Eric L Schneider has been associated with prominent organizations such as Prolynx LLC and the University of California. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Schneider's notable coworkers include Gary W Ashley and Brian R Hearn. Their collaborative efforts have further advanced the research and development of innovative biotechnological solutions.

Conclusion

Eric L Schneider's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical therapies and drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…